Vaccine and Treatment Evaluation Units
About
What services does this resource provide?
The Vaccine and Treatment Evaluation Units (VTEUs), supported by the Division of Microbiology and Infectious Diseases (DMID) since the 1960’s, comprise a consortium of individual contracts within academic centers and organizations that provide a ready resource for the conduct of clinical trials to evaluate promising vaccines and treatments for infectious diseases.
The VTEUs conduct a broad range of studies including Phase I, Phase 2, Phase 3 and Phase 4 clinical trials of bacterial, viral and parasitic vaccines, therapeutics and other biologics and drugs as preventive and therapeutic measures against infectious diseases in people of all ages and risk categories. The VTEUs can also undertake a variety of other studies that support product development such as evaluations of novel investigational product delivery systems and reevaluation of current vaccine formulations and schedules of delivery. Some VTEU contract sites have established subcontracts with additional investigational sites.
Who provides the services?
There are eight current VTEU contract award sites.
Access
back to top